Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

Part of paid clinical trials in San Francisco, California.

Sponsor
California Pacific Medical Center Research Institute
Study ID
NCT01750619
Status
Recruiting
Apply to this trial

Conditions

  • Benign Neoplasm of Intestinal Tract
  • Gastrointestinal Neoplasms

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.

Key Dates

Start date
Jul 31, 2011
Status verified
Mar 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
8,000 participants (estimated)

Arms

  • Arm: Mucosal tumors of the colon
    Patients who received endoscopic treatment for noninvasive mucosal tumors of the colon.
  • Arm: Nonampullary tumors of the duodenum
    Patients who received endoscopic treatment for noninvasive mucosal tumors of the duodenum.
  • Arm: Ampullary tumors
    Patients who received endoscopic treatment for noninvasive ampullary tumors.

Primary Outcome Measure

Technical success. [ Time Frame: 1 day to 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Interventional Endoscopy ServicesSan FranciscoCalifornia94115
Jona C Bernabe
[email protected]

Find similar trials in San Francisco, CA

By research site
Interventional Endoscopy Services· San Francisco, CA

Related Studies